skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Global Search Configuration

Refine Results

Clear All

Specialism

Show More

Resources

Show More

Products

Show More

Show More

49 Total results for product and free and sample content found

In Vivo, Pink Sheet

Manufacturing and Distribution: Challenges and Opportunities

13 May 2021

Manufacturing and Distribution eBook

The COVID-19 pandemic has brought about significant manufacturing and distribution challenges and opportunities for Pharma. Seize new opportunities and avoid risk with the strategic commercial and regulatory intelligence you need to stay competitive by subscribing to Pink Sheet and In Vivo.

Topic Strategy

In Vivo

From US To EU: Young Biotechs Going It Alone

By Jo Shorthouse 27 Nov 2020

Analysis

Europe’s patchwork of reimbursement agencies make it a daunting place for a small US biotech to do business. Traditionally large pharma partners or CMSOs have provided an experienced hand to hold, but as a new wave of gene therapies and orphan drugs get the EMA green light, smaller drug developers are applying innovation to commercialization and choosing to go solo.

Topic Market Access Rare Diseases Strategy

In Vivo

ESG In 2020: Not A Tick-Box Exercise But A Strategic Opportunity

By William Looney 27 Nov 2020

ESG_In_2020_1

The idea that public corporations have obligations that extend beyond the fiduciary responsibility to shareholders will be the dominant measure of responsible business behavior in the coming decade. Uncertainty about the extent of these commitments – commonly referenced as the environmental, social and governance (ESG) agenda – has produced equally variable responses from companies in the health care business.

Topic Financing Strategy

Generics Bulletin

Biocon Biologics Gets True North Investment

By Vibha Ravi 27 Nov 2020

Biocon_Biologics_Gets_True_North_Investment

Private equity group True North continues to back the Biocon group and is picking up a minority stake in Biocon Biologics in a deal that values the subsidiary at $3bn. Separately, another subsidiary, Biocon Biosphere, has also been set up as part of efforts to unlock the full potential of the business.

Topic Deals Strategy

In Vivo

COVID-19: Global Perspective Infographic

21 Jul 2020

COVID-19 Global Perspective

Your snapshot view of how the life sciences in nations around the globe are responding to the COVID-19 pandemic is now available. Register today to receive your free World Vision 360° infographic from In Vivo. 

Topic Strategy Research & Development

In Vivo

World Vision 360° Pack

21 Jul 2020

World_Vision_360

Get a global perspective on the current state of the pharma and medtech industries with In Vivo’s World Vision 360° article pack. Access your free pack for essential insights into research and development, innovations, trends and strategies for markets around the world.

Topic Research & Development Strategy

Scrip

Pharma Can Reset Reputation In Pandemic, Says Novartis CEO

By Kevin Grogan 01 May 2020

virtual-smile

Vas Narasimhan hopes that donations and the "unprecedented collaborations" between drugmakers trying to overcome the COVID-19 pandemic is leading to a shift in the perception of the value of the sector to society.

Topic Coronavirus Leadership Strategy

Generics Bulletin

Celltrion Sets Out Strategy For China

By David Wallace 27 Jan 2020

Celltrion_Sets_Out_Strategy_For_China

Celltrion has unveiled plans to construct a biologics plant in Wuhan, China, as well as setting up a direct sales network in the country, as part of its wider global strategy that also involves launching a new biosimilar every year to 2030.

Topic China Manufacturing Strategy

Scrip

Pharma Finds Its Way in AI

By Leah Samuel 06 Dec 2019

Analysis

Early adopters of artificial intelligence are discovering how best to use it. Some of them are sharing lessons they have learned. 

Topic Artificial Intelligence Research & Development Strategy

Next steps

Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.

Request live demo now:

Our team is ready to hear from you for a particular request or area of interest. Please do not hesitate to reach out and discuss.

Contact us for product technical and account support.

  • US Toll-Free   : +1 888 670 8900 
  • US Toll             : +1 212-600-3520
  • UK & Europe : +44 (0) 208 052 0700

Have an immediate and specific information need?

Browse and buy from 1000s of analysis and research reports now: